Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?

By Cameron David   Douglas Sharon   Brown Janet   Anderson Richard  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 805-814

Springer Publishing Company

Access to resources Recommend Favorite

Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women

By Reinier Kyndaron   Vacek Pamela   Geller Berta  

Breast Cancer Research and Treatment, Vol. 103, Iss. 3, 2007-07 ,pp. : 343-348

Springer Publishing Company

Access to resources Recommend Favorite

Bone mineral density and risk of postmenopausal breast cancer

By Grenier Debjani  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 679-686

Springer Publishing Company

Access to resources Recommend Favorite

Bone Mineral Density and Endogenous Hormones and Risk of Breast Cancer in Postmenopausal Women (United States)

By Buist D.S.M.  

Cancer Causes and Control, Vol. 12, Iss. 3, 2001-04 ,pp. : 213-222

Springer Publishing Company

Access to resources Recommend Favorite

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer-a randomised study with more than 10 years follow-up from the danish breast cancer cooperative gr

By Andersson M.   Lindegaard Madsen E.   Overgaard M.   Rose C.   Dombernowsky P.   Mouridsen H.T.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite